MT1L and colorectal carcinoma: A notable correlation between low MT1B, MT1H, or MT1L expression and an increased risk of adverse outcomes was identified.420 Additionally, a distinct four-gene model, consisting of MT1F, MT1G, MT1L, and MT1X, effectively predicted survival and CRC prognosis.